Acute myelomonocytic leukemia during pembrolizumab treatment for non-small cell lung cancer: A case report

Figure 1 Contrast-enhanced neck computed tomography, contrast-enhanced chest computed tomography, and ¹⁸F-fluorodeoxyglucose positron emission/computed tomography. A: 41 mm × 64 mm sized bulky necrotizing lymphadenopathy in left cervical level V; B: Multiple various sized necrotizing lymphadenopathy on both cervical level II to V; C: Contrast-enhanced chest computed tomography shows 2 cm sized heterogeneous enhanced nodule in anterior segment of left upper lobe (LUL); D: Large periosseous mass formation involving lateral arc of left 7^th rib; E: ¹⁸F-fluorodeoxyglucose positron emission/computed tomography showed a hypermetabolic nodule in LUL; F: Multiple enlarged hypermetabolic mass on both cervical level II to IV, and hypermetabolic mass on left 7^th rib.